Biotelemetry Inc. buy tamam
Start price
05.05.17
/
50%
€25.30
Target price
26.04.18
€35.18
Performance (%)
35.58%
End price
26.04.18
€34.30
Summary
This prediction ended on 26.04.18 with a price of €34.30. With a performance of 35.58% the BUY prediction by tamam was a big success. tamam has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Biotelemetry Inc. | - | - | - | - |
iShares Core DAX® | -0.621% | 1.080% | 11.291% | 16.439% |
iShares Nasdaq 100 | -4.503% | -5.432% | 22.172% | 39.304% |
iShares Nikkei 225® | -2.562% | -1.617% | 7.262% | 8.383% |
iShares S&P 500 | -1.706% | -1.223% | 22.550% | 40.997% |
Comments by tamam for this prediction
In the thread Biotelemetry Inc. diskutieren
BioTelemetry: It's a buying opportunity as
the LifeWatch deal is still very much intact, and investors should consider a particularly tough comp BEAT had this quarter.
https://seekingalpha.com/article/4130067-biotelemetry-key-partnership-apples-heart-study-featuring-apples-watch
(Vom Mitglied beendet)